| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |